Novel Coronavirus (SARS-CoV-2/COVID-19)
In a letter to Secretary Mnuchin and IRS Commissioner Rettig, the AHA, AAMC and Catholic Health Association request that the IRS provide a six-month automatic extension for filing Forms 990, 990-T, and 4720 to any Section 501(c)(3) organization that is required to file Form 990, Schedule H. In…
The Coronavirus Aid, Relief and Economic Security (CARES) Act authorized $2.2 trillion in new spending to help individuals and businesses weather the economic downturn caused by COVID-19, as well as to provide critical resources to the health care system.
Here are some of the latest developments in how hospitals and health systems are leveraging digital tools and technology to handle the rapid influx of novel coronavirus patients. Please note that we are suspending publication of Market Scan to focus on bringing you important tools, resources and…
The Vice President, on behalf of President Trump and the White House Coronavirus Task Force, yesterday sent a letter to the nation's hospitals requesting that all hospitals report certain data on COVID-19 testing results, bed and ventilator capacity. In the letter, hospitals were asked to report…
The Partnership to Amend 42 CFR Part 2, a coalition of nearly 50 health care organizations including the AHA, applauded Congress’ important step to modernize privacy regulations affecting the disclosure of patients’ substance use disorder treatment records.
The Joint Commission has issued a new standards FAQ on monitoring patients at high risk for suicide who have known or suspected COVID-19.
The Food and Drug Administration expanded and updated guidance on the emergency use authorization for personal protective equipment.
Getting health care workers on the front line the personal protective equipment they need is the main focus right now for hospital and health system leaders, AHA President and CEO Rick Pollack said on CNN.
The Centers for Medicare & Medicaid Services announced additional details about its implementation of reporting exceptions and extensions across is quality reporting and value programs.
The Food and Drug Administration Friday authorized emergency use of the ID NOW Instrument in patient care settings to quickly test for COVID-19 through direct nasal or throat swab testing.